Medicare Enrolled

Dr. James Cooper, M.D.

Neurology · Greenville, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
498A RED BANKS ROAD, Greenville, NC 27858
2522153067
In practice since 2006 (19 years)
NPI: 1356436745 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cooper from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cooper? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cooper

Dr. James Cooper is a neurology specialist in Greenville, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cooper performed 710 Medicare services across 384 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cooper received a total of $265,757 from 66 pharmaceutical and/or device companies across 1138 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cooper is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 29% volume in NC $265,757 industry payments

Medicare Practice Summary

Medicare Utilization ↗
710
Medicare services
Top 29% in NC for neurology
384
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~37 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
377 $1 $5
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
83 $77 $175
Betamethasone steroid injection
An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate.
43 $5 $10
Trigger point injection, 1-2 muscles
A procedure involving the injection of medication into one or two specific muscles to treat trigger points.
40 $14 $69
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
38 $113 $294
Injection of anesthetic agent and/or steroid into other nerve or branch 36 $63 $192
Injection of anesthetic or steroid into upper neck and back of head nerve
An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head.
34 $34 $202
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
34 $44 $125
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
25 $140 $342
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2023 ↗
$265,757
Total received (2018-2023)
Avg $44,293/year across 6 years
Top 2% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
1,138
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$253,726 (95.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,031 (4.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$502
2022
$31,564
2021
$62,142
2020
$42,855
2019
$62,727
2018
$65,966

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$74
Amneal Pharmaceuticals LLC
$59
Otsuka America Pharmaceutical, Inc.
$44
AbbVie Inc.
$35
Merck Sharp & Dohme LLC
$29
PFIZER INC.
$26
Lundbeck LLC
$24
Corium, LLC
$23
Lilly USA, LLC
$22
GENZYME CORPORATION
$20
UPSHER-SMITH LABORATORIES LLC
$18
Amgen Inc.
$18
Avion Pharmaceuticals
$17
EMD Serono, Inc.
$17
UCB, Inc.
$16
IMPEL PHARMACEUTICALS INC.
$16
Celgene Corporation
$16
Kowa Pharmaceuticals America, Inc.
$15
Merz Pharmaceuticals, LLC
$14
Top 3 companies account for 35.1% of 2023 payments
All-time payments by company (2018-2023) ›
Amgen Inc.
$108,837
Teva Pharmaceuticals USA, Inc.
$61,140
AbbVie Inc.
$22,740
ABBVIE INC.
$21,177
Biohaven Pharmaceuticals, Inc.
$15,889
Allergan, Inc.
$14,504
Assertio Therapeutics, Inc.
$6,977
UPSHER-SMITH LABORATORIES LLC
$4,080
Biohaven Pharmaceutical Holding Company Ltd.
$2,592
Novartis Pharmaceuticals Corporation
$874
GENZYME CORPORATION
$672
Amneal Pharmaceuticals LLC
$557
Supernus Pharmaceuticals, Inc.
$545
Avanir Pharmaceuticals, Inc.
$437
Collegium Pharmaceutical, Inc.
$330
Neurocrine Biosciences, Inc.
$314
UCB, Inc.
$302
Lilly USA, LLC
$243
Acorda Therapeutics, Inc
$216
Biogen, Inc.
$215
IMPEL PHARMACEUTICALS INC.
$168
US WorldMeds, LLC
$163
Sunovion Pharmaceuticals Inc.
$159
Impax Laboratories, Inc.
$153
Janssen Pharmaceuticals, Inc
$151
Upsher-Smith Laboratories LLC
$148
Bausch Health US, LLC
$145
Lundbeck LLC
$141
ASSERTIO THERAPEUTICS, Inc.
$119
Merz North America, Inc.
$114
Merck Sharp & Dohme LLC
$105
Daiichi Sankyo Inc.
$99
Celgene Corporation
$97
ARBOR PHARMACEUTICALS, INC.
$96
ACADIA Pharmaceuticals Inc
$92
EMD Serono, Inc.
$91
Allergan Inc.
$88
Merz Pharmaceuticals, LLC
$80
Avion Pharmaceuticals
$80
Scilex Pharmaceuticals Inc.
$73
Zyla Life Sciences, Inc.
$60
Pernix Therapeutics Holdings, Inc.
$59
Horizon Therapeutics plc
$59
Merck Sharp & Dohme Corporation
$59
Currax Pharmaceuticals LLC
$53
Vertical Pharmaceuticals, LLC
$48
Otsuka America Pharmaceutical, Inc.
$44
Kaleo, Inc.
$43
Zyla Life Sciences
$36
Banner Life Sciences, LLC
$34
MERZ NORTH AMERICA, INC.
$34
PFIZER INC.
$26
Corium, LLC
$23
Arbor Pharmaceuticals, Inc.
$18
Kowa Pharmaceuticals America, Inc.
$15
Horizon Pharma plc
$15
Adamas Pharmaceuticals, Inc.
$15
Promius Pharma LLC
$15
AstraZeneca Pharmaceuticals LP
$14
E.R. Squibb & Sons, L.L.C.
$13
Almatica Pharma LLC
$12
Nevro Corp.
$12
Mallinckrodt Enterprises LLC
$12
BANNER LIFE SCIENCES, LLC
$11
Neurelis, Inc.
$11
Egalet US Inc
$11
Top 3 companies account for 72.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Belbuca · Briviact · CAMBIA · CONTRAVE · COPAXONE · Cambia · DUEXIS · Dhivy · ELYXYB - celecoxib · EMGALITY · EVZIO · Evzio · GILENYA · GOCOVRI · GRALISE · Gralise · Horizant · INBRIJA · INGREZZA · INVEGA SUSTENNA · KESIMPTA · KYNMOBI · LEMTRADA · LORZONE · MAVENCLAD · MAYZENT · METHYLPHENIDATE 72 · MIGRANAL · MOVANTIK · MYOBLOC · Mavenclad · Morphabond ER · Movantik · NAPRELAN · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nucynta · Nuedexta · OXTELLAR XR · Omnia · Ongentys · PENNSAID · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RAYOS · RELEXXII · RYTARY · Rebif · SEGLENTIS · SILENOR · SPRAVATO · SPRIX · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · Trudhesa · UBRELVY · VALTOCO · VIMOVO · VUMERITY · VYEPTI · Vimpat · XEOMIN · XTAMPZA · Xadago · Xeomin · Xtampza ER · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZOHYDRO ER · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for neurology in NC.

Looking for a neurology specialist in Greenville?
Compare neurologists in the Greenville area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
13
Per 100K population
7.5
County median income
$58,851
Nearest hospital
ECU HEALTH MEDICAL CENTER
10.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cooper is a clinical cardiology specialist, with above-average Medicare volume (top 29% in NC), with speaking/promotional industry engagement in the top 2% of NC peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Cooper experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Cooper performed 377 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cooper receive payments from pharmaceutical companies?
Yes. Dr. Cooper received a total of $265,757 from 66 companies across 1,138 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cooper's costs compare to other neurologists in Greenville?
Dr. Cooper's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cooper) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →